Antigone Argyriou, MD
Pain Medicine · Islip, NYNPI 1902110166
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $10,168 of the $14,551 with a category attached, or 69.9%. 41 manufacturers reported payments, led by Medtronic at 28.7% of the total. 2025 is the largest year on record at $4,553, 2.3 times the $1,999 reported in 2019.
Across 292 payments — averaging $49.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$4K
- Boston Scientific$4K
- Relievant Medsystems, Inc.$2K
- SPR Therapeutics, Inc$765
- DJO, LLC$668
- AbbVie$626
- plus $3K from 35 others
What the payments were for
- Travel & lodging$4,38330%
- Food & beverage$10,16870%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 46 | $4,173 |
| Boston Scientific | 93 | $3,779 |
| Relievant Medsystems, Inc. | 22 | $1,773 |
| SPR Therapeutics, Inc | 8 | $765 |
| DJO, LLC | 14 | $668 |
| AbbVie(2 entities) | 29 | $626 |
| Amgen(2 entities) | 3 | $321 |
| Novartis | 20 | $286 |
| Biogen | 4 | $265 |
| Centinel Spine, LLC | 5 | $229 |
| Spinefrontier, Inc. | 1 | $204 |
| Brixton Biosciences, Inc. | 2 | $189 |
| Novo Nordisk | 1 | $125 |
| Johnson & Johnson | 1 | $125 |
| Orthofix Medical, Inc. | 3 | $123 |
| Vertos Medical, Inc. | 1 | $82 |
| Si-bone, Inc. | 1 | $81 |
| Nevro Corp. | 4 | $71 |
| Nalu Medical, Inc. | 2 | $70 |
| Saluda Medical Americas, Inc. | 3 | $69 |
| Stryker | 1 | $60 |
| Lundbeck LLC | 4 | $52 |
| Abbott | 3 | $46 |
| Avanos Medical | 2 | $45 |
| UCB, Inc. | 2 | $36 |
| Zogenix Inc. | 1 | $25 |
| Alnylam Pharmaceuticals Inc. | 1 | $24 |
| Heron Therapeutics, Inc. | 1 | $23 |
| Pfizer | 2 | $22 |
| Spine Wave, Inc. | 1 | $21 |
| Mallinckrodt Hospital Products Inc. | 1 | $21 |
| Avanir Pharmaceuticals, Inc. | 1 | $19 |
| Sanofi | 1 | $18 |
| Lilly USA, LLC | 1 | $17 |
| Supernus Pharmaceuticals, Inc. | 1 | $15 |
| GE HealthCare | 1 | $15 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
| Lenoss Medical Inc | 1 | $14 |
| Almatica Pharma LLC | 1 | $13 |
| Acadia Pharmaceuticals Inc | 1 | $13 |
| Molnlycke Health Care US, LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Intracept$5,470
- GENERAL - THERAPIES$1,089
- SYNCHROMEDII$1,017
- ADAPTIVESTIM$983
- SPRINT PNS System$520
- INTELLIS ADAPTIVESTIM$465
- CMF$356
- UPLIZNA$293
- WaveWriter Alpha Prime 16$216
- InSpan$204
- SIJFuse$204
- GENERAL PAIN MANAGEMENT$172
- Neural Ice$160
- MYSTIM$152
- STEALTHSTATION S8 PLATFORM$148
- BOTOX$127
- Teligen$125
- TECFIDERA$121
- TYSABRI$113
- Vumerity$113
How this compares
$14,551 in reported general payments places this provider in the 85th percentile of 503 pain medicine providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BelbucaBuprenorphine Hcl | 16 | $7,269 |
| Buprenorphine | 13 | $2,910 |
| Lidocaine-PrilocaineLidocaine/Prilocaine | 29 | $1,344 |
| Lidocaine | 15 | $1,066 |
| Morphine Sulfate | 27 | $925 |
| Diclofenac Sodium | 12 | $798 |
| Pregabalin | 41 | $795 |
| Tramadol Hcl ErTramadol Hcl | 11 | $571 |
| Celecoxib | 14 | $568 |
| Duloxetine Hcl | 45 | $530 |
| Oxycodone Hcl | 34 | $475 |
| Tramadol Hcl | 79 | $384 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 47 | $361 |
| Gabapentin | 58 | $337 |
| Tizanidine Hcl | 28 | $286 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Islip
- Gary SchwartzBrooklyn$756K
- Amitabh GulatiNew York$614K
- William CaldwellStony Brook$530K
- Brian DurkinPort Jefferson$455K
- David SpinnerNew York$391K
- Grace FordeNew Hyde Park$355K
- Romanth WaghmaraeHamburg$158K
- Samuel BrownSouthold$147K
- Fred CohenBronx$141K
- Eric LeeNew York$117K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.